ABC - AmerisourceBergen Corporation

NYSE - NYSE Delayed Price. Currency in USD
93.23
+1.06 (+1.15%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Previous Close92.17
Open92.03
Bid80.00 x 800
Ask106.27 x 1200
Day's Range91.69 - 93.58
52 Week Range71.90 - 106.27
Volume640,624
Avg. Volume1,554,815
Market Cap20.492B
Beta1.18
PE Ratio (TTM)24.16
EPS (TTM)3.86
Earnings DateAug 1, 2018 - Aug 6, 2018
Forward Dividend & Yield1.52 (1.60%)
Ex-Dividend Date2018-05-18
1y Target Est102.87
Trade prices are not sourced from all markets
  • Munger: Single payer medicine will come when the Democrats gain control of both Houses and the White House
    Yahoo Finance Video2 months ago

    Munger: Single payer medicine will come when the Democrats gain control of both Houses and the White House

    At the Berkshire Hathaway annual shareholder meeting, Warren Buffett and Charlie Munger discuss health care and finding a better way to provide it.

  • ACCESSWIRE9 days ago

    Stock Performance Review on Rite Aid and Three Other Services Stocks

    Gains were broad based as seven out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Services stocks: GNC Holdings Inc. (NYSE: GNC), Rite Aid Corp. (NYSE: RAD), Walgreens Boots Alliance Inc. (NASDAQ: WBA), and AmerisourceBergen Corp. (NYSE: ABC).

  • See what the IHS Markit Score report has to say about AmerisourceBergen Corp.
    Markit13 days ago

    See what the IHS Markit Score report has to say about AmerisourceBergen Corp.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Services sector is rising.

  • What is Behind AmerisourceBergen Corporation’s (NYSE:ABC) Superior ROE?
    Simply Wall St.14 days ago

    What is Behind AmerisourceBergen Corporation’s (NYSE:ABC) Superior ROE?

    With an ROE of 25.26%, AmerisourceBergen Corporation (NYSE:ABC) outpaced its own industry which delivered a less exciting 13.80% over the past year. On the surface, this looks fantastic since weRead More...

  • AmerisourceBergen picks new headquarters location
    American City Business Journals15 days ago

    AmerisourceBergen picks new headquarters location

    In a much-anticipated decision, the largest public company in Greater Philadelphia chooses Conshohocken as its new corporate home.

  • The Wall Street Journal15 days ago

    Under Pressure to Tighten Supply Chain, Drug Companies Look to Blockchain

    Under federal pressure to tighten the pharmaceutical supply chain and keep drugs from falling into the wrong hands, drug companies are ramping up experiments with promising but unproven blockchain technologies. AmerisourceBergen Corp. and Merck & Co. Inc. plan to expand a test project completed last year that tracked the ownership of drugs moving through the health-care supply chain. The new test will increase the number of drugs and health-care devices and perform more complex transactions, said Dale Danilewitz, chief information officer at the drug distributor.

  • AmerisourceBergen (ABC) Down 8.7% Since Earnings Report: Can It Rebound?
    Zacks20 days ago

    AmerisourceBergen (ABC) Down 8.7% Since Earnings Report: Can It Rebound?

    AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Analyzing CVS Health and Walgreens’ Acquisitions
    Market Realist22 days ago

    Analyzing CVS Health and Walgreens’ Acquisitions

    Recent efforts to expand their footprints have impacted Walgreens (WBA) and CVS Health’s (CVS) share prices. CVS has faced investors’ skepticism about its plans to acquire Aetna.

  • CVS Health and Walgreens’ Stock Prices Fell
    Market Realist22 days ago

    CVS Health and Walgreens’ Stock Prices Fell

    Drugstore stocks have been under pressure in the past year due to fears of Amazon (AMZN) entering the pharma space, President Trump’s drug pricing policy change, and the ongoing consolidation wave in the industry.

  • Add Bucks County to list of those suing opioid manufacturers, distributors
    American City Business Journals22 days ago

    Add Bucks County to list of those suing opioid manufacturers, distributors

    The county is seeking unspecified damaged. Among the opioid epidemic-related costs Bucks County claims to have incurred is a $20 million prison expansion project.

  • Two Greater Philadelphia companies drop off Fortune 500. See where local companies ranked.
    American City Business Journals23 days ago

    Two Greater Philadelphia companies drop off Fortune 500. See where local companies ranked.

    The region is now home to 14 members of the annual list of the 500 highest grossing U.S. companies, with another 13 being ranked between No. 501 and No. 1000.

  • CNBClast month

    Investors have shrugged off Trump drug price plan, but it is still early days

    The FDA released a list of drugmakers it said are getting in the way of generic drug development. Stocks of pharmacy benefit managers and biotech companies still outperformed the market. The biopharma and drug supply chain sectors outperformed the market last week, even as Trump administration officials pressed the president's blueprint to lower drug prices, with tough rhetoric for drugmakers and public shaming of pharmaceutical firms for supposedly blocking competition.

  • Biopharma Stocks Fly As Trump Speech Seen As 'More Bark Than Bite'
    Investor's Business Dailylast month

    Biopharma Stocks Fly As Trump Speech Seen As 'More Bark Than Bite'

    Big Pharma and biotech stocks popped Friday after a drug-pricing speech from President Trump was consistent with views that he would offer "more rhetoric than reform."

  • The Wall Street Journallast month

    [$$] Opioid Shipments to Small Towns Come Under Spotlight at Hearing

    WASHINGTON—Prescription-drug wholesalers that for years shipped hundreds of opioid pills per person to small towns in West Virginia mostly denied they were a cause of surging addiction as lawmakers grilled them on Tuesday. Most company executives told a House hearing that their companies’ actions didn’t fan the opioid epidemic in the state. Only one executive, Joseph Mastandrea, chairman of Miami-Luken Inc. said that his company had a “shared responsibility” for the opioid crisis.

  • TheStreet.comlast month

    Congressional Committee Grills Drug Distributors on Opioid Crisis Roles

    and H.D. Smith Wholesale Drug Company told the House Committee on Energy and Commerce their companies did not contribute to the opioids epidemic. The five drug distribution companies were ordered to appear before the committee on Tuesday, May 8. Since last May the committee has been investigating the number of opioid pills that were shipped to West Virginia.

  • Cardinal Health's George Barrett apologizes for massive opioid shipments to W.Va.
    American City Business Journalslast month

    Cardinal Health's George Barrett apologizes for massive opioid shipments to W.Va.

    George Barrett, executive chairman and past CEO of Cardinal Health Inc., apologized before a Congressional committee investigating the role of drug distributors in sending millions of doses of opioids to questionable pharmacies, particularly two in rural West Virginia. Barrett explained today's procedures would have blocked the shipments.

  • CNBClast month

    Here's what to expect when Trump outlines his policy to bring down drug prices

    President Donald Trump is expected to outline new policies to deliver on his pledge to bring prices down in a speech that could come this week. The need to bring down high drug prices may be one of the few health care issues that draw bipartisan support in Washington and on Main Street.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of ABC earnings conference call or presentation 2-May-18 12:30pm GMT

    Q2 2018 AmerisourceBergen Corp Earnings Call

  • Stock Market News For May 3, 2018
    Zacks2 months ago

    Stock Market News For May 3, 2018

    Wall Street suffered losses on Wednesday as all three major indexes closed in the red

  • With A -27.23% Earnings Drop, Is AmerisourceBergen Corporation’s (NYSE:ABC) A Concern?
    Simply Wall St.2 months ago

    With A -27.23% Earnings Drop, Is AmerisourceBergen Corporation’s (NYSE:ABC) A Concern?

    Assessing AmerisourceBergen Corporation’s (NYSE:ABC) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check to buildRead More...

  • AmerisourceBergen (ABC) Q2 Earnings Top, FY18 View Solid
    Zacks2 months ago

    AmerisourceBergen (ABC) Q2 Earnings Top, FY18 View Solid

    AmerisourceBergen (ABC) registers strong growth in the Pharmaceutical Distribution segment and World Courier business in Q2.

  • Reuters2 months ago

    AmerisourceBergen sees Memphis plant back on track by 2019; shares rise

    Drug distributor AmerisourceBergen Corp posted a better-than-expected quarterly profit on Wednesday and said it expects its Memphis facility to be fully operational by fiscal 2019, sending its shares up 5 percent. The company has spent about $22 million since the beginning of the year to fix problems at the facility, Chief Financial Officer Tim Guttman said on a conference call, adding any income contribution this year is expected to be nominal. The Memphis plant was acquired as part of a 2015 buy of PharMEDium Healthcare Holdings and has remained closed since December following inspections by the U.S. Food and Drug Administration.

  • AmerisourceBergen (ABC) Beats on Q2 Earnings & Revenue
    Zacks2 months ago

    AmerisourceBergen (ABC) Beats on Q2 Earnings & Revenue

    AmerisourceBergen (ABC) gains on strong segmental performance and solid guidance in Q2.

  • MarketWatch2 months ago

    AmerisourceBergen shares rise 2% after Q2 profit, revenue beats

    AmerisourceBergen Corp. shares rose 2.2% in premarket trade Wednesday after the company reported second-quarter profit and revenue beats. Adjusted earnings-per-share came to $1.94, above the FactSet consensus of $1.82. Revenue rose to $41.03 billion from $37.15 billion, above the FactSet consensus of $40.55 billion.

  • Associated Press2 months ago

    AmerisourceBergen: Fiscal 2Q Earnings Snapshot

    The Chesterbrook, Pennsylvania-based company said it had profit of $1.29 per share. Earnings, adjusted for one-time gains and costs, came to $1.94 per share. The results exceeded Wall Street expectations. ...